Viking Therapeutics (VKTX) Cash & Equivalents (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Cash & Equivalents came in at $125.8 million in Q2 2026, up 271.16% year-over-year from $33.9 million in Q2 2025, and up 6.46% quarter-over-quarter from $118.1 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Cash & Equivalents (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Cash & Equivalents across 13 years of filings, most recently posting $125.8 million for Q2 2026.
- In Q2 2026, Cash & Equivalents rose 271.16% year-over-year to $125.8 million; the TTM figure through Jun 2026 stood at $125.8 million (up 271.16% YoY), while the FY2025 annual figure was $165.8 million, up 521.57% from the prior year.
- Cash & Equivalents came in at $125.8 million for Q2 2026 at Viking Therapeutics, up from $118.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $195.6 million in Q1 2024 to a low of $18.4 million in Q1 2023.
- Average Cash & Equivalents over 5 years is $82.0 million, with a median of $52.9 million recorded in 2023.
- Year-over-year, Cash & Equivalents surged 1629.43% in 2022 and sank 89.72% in 2023.
- Over 5 years, Cash & Equivalents stood at $36.6 million in 2022, then surged by 51.55% to $55.5 million in 2023, then slumped by 51.95% to $26.7 million in 2024, then soared by 521.57% to $165.8 million in 2025, then declined by 24.16% to $125.8 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $125.8 million in Q2 2026, $118.1 million in Q1 2026, and $165.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 125.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.75 Mn |
| Mar 31, 2026 | 118.12 Mn |
| Dec 31, 2025 | 165.81 Mn |
| Sep 30, 2025 | 100.38 Mn |
| Jun 30, 2025 | 33.88 Mn |
| Mar 31, 2025 | 37.94 Mn |
| Dec 31, 2024 | 26.68 Mn |
| Sep 30, 2024 | 50.35 Mn |
| Jun 30, 2024 | 43.92 Mn |
| Mar 31, 2024 | 195.58 Mn |
| Dec 31, 2023 | 55.52 Mn |
| Sep 30, 2023 | 37.19 Mn |
| Jun 30, 2023 | 69.52 Mn |
| Mar 31, 2023 | 18.36 Mn |
| Dec 31, 2022 | 36.63 Mn |
| Sep 30, 2022 | 29.41 Mn |
| Jun 30, 2022 | 152.69 Mn |
| Mar 31, 2022 | 178.61 Mn |
| Dec 31, 2021 | 26.37 Mn |
| Sep 30, 2021 | 11.26 Mn |
API Access
Viking Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();